European Lithium Limited · ISIN: AU000000EUR7 · Research | Analyses | Ratings

Buy

Original-Research: European Lithium Limited - from First Berlin Equity Research GmbH 20.12.2024 / 16:41 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions. Classification of First Berlin Equity Research GmbH to European Lithium Limited Company Name: European...

ASX:EUR Price indication powered by TradingView

About the publication

+++ Corporate Insights +++- Company news, directors dealings, net short positions

Just become a member of the community.

Current analyst assessments

On this page you will find current analyst assessments of renowned research houses, which make their assessments on the business development of listed companies available for publication and distribution via our content partner EQS-Newswire.
Ratings
Buy
Sell
Reduce
Hold
New admission
Suspended
All Sources
Hardman & Co.
Edison
BankM
East Value
First Berlin
GBC
Montega
NuWays
Parmantier & Cie.
Sphene Capital
New mwb Research
Reset Filter
This might be interesting for you as well
Equity Story (4)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
Source: First Berlin Equity Research GmbH
11 June 2024 10:36AM
Buy
US1508376076
Original-Research: CEL-SCI Corporation - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to CEL-SCI Corporation Company Name: CEL-SCI Corporation ISIN: US1508376076 Reason for the research: Update Recommendation: Buy from: 11.06.2024 Target price: USD 6.20 Target price on sight of: 12 months Last rating c...
CEL-SCI Corporation
About the publication
Source: First Berlin Equity Research GmbH
14 February 2024 03:51PM
Buy
US1508376076
Original-Research: CEL-SCI Corporation - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu CEL-SCI Corporation Unternehmen: CEL-SCI Corporation ISIN: US1508376076 Anlass der Studie: Update Empfehlung: Buy seit: 14.02.2024 Kursziel: USD 8.40 Kursziel auf Sicht von: 12 months Letzte Ratingänderung: - Analyst: ...
CEL-SCI Corporation
About the publication
Source: First Berlin Equity Research GmbH
05 December 2023 03:46PM
Buy
US1508376076
Original-Research: CEL-SCI Corporation - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu CEL-SCI Corporation Unternehmen: CEL-SCI Corporation ISIN: US1508376076 Anlass der Studie: Initiation of coverage Empfehlung: Buy seit: 05.12.2023 Kursziel: USD8.40 Kursziel auf Sicht von: 12 months Letzte Ratingänderu...
CEL-SCI Corporation
About the publication
More CEL-SCI Corporation related information
Type Total Last Made by Go to
Equity Story 4 4th September 2024 EQS Group AG EQS
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Info
The information presented here was provided by our content partner EQS. The assessments of the analyst houses were transmitted in the original via the news service EQS-Newswire for publication via the affiliated distribution networks.
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.